Page 21 - 2024 Westchester County Economic Development Guide

Leading Edge Collaborations
Acquisition of Decibel Therapeutics for Gene Therapy Development: In September 2023, Regeneron strengthened its partnership with Decibel Therapeutics by acquiring
the company. The following month, they shared some promising early results from a trial on a new gene therapy that shows potential to help people with severe hearing loss caused by genetics.
Partnership for COVID-19 Treatment Development:
Regeneron made a deal with a U.S. government agency, BARDA, to help develop, produce, and get official approval for a new COVID-19 antibody treatment.
Nurturing Future Scientific Innovators
In 2023, Regeneron continued to sponsor several key science fairs and events, like the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair, and the Regeneron Westchester Science and Engineering Fair.
Regeneron and the Society for Science announced that Regeneron will be increasing and extending its support for the Regeneron International Science and Engineering Fair, the world’s largest global pre-college science and engineering competition, investing about $34 million over the next five years.
Regeneron Genetics Center became a founding partner of the Together for CHANGETM initiative, which aims to improve healthcare for people of African ancestry and address inequities in STEM careers and research.
Advancing Corporate Citizenship
The company has been recognized on the Dow Jones Sustainability World Index for the fifth year in a row, highlighting its commitment to sustainable practices.
In 2023, Regeneron employees set a new company record by volunteering over 23,000 hours in the company's seventh annual "Day for Doing Good." More than 6,700 Regeneron volunteers participated, reflecting the company's strong commitment to community service.
"We have been a proud New York company since our beginning over three decades ago, during which time we have invented industry-leading drug discovery technology and developed ten FDA-approved or authorized medicines entirely in our own laboratories. New York State has played an important role in our success by consistently recognizing the value of innovation, fostering an inclusive and dynamic biomedical industry, and helping to attract top talent to the region.”
—Regeneron Co-Founder, Board Co-Chair, President and CEO Leonard S. Schleifer, M.D., Ph.D.
WESTCHESTER COUNTY ECONOMIC DEVELOPMENT GUIDE 19
© Courtesy of Regeneron © Courtesy of Regeneron © Courtesy of Regeneron